LIDOCAINE HCL VISCOUS (LIDOCAINE HCL)
- Administration of local anesthesia
- Mouth irritation
- Suppression of the gag reflex
Lidocaine Viscous 2 % mucosal solution
- 15 milliliters and swish and spit out by oral route every 3 hours
lidocaine 2 % mucosal solution
- 15 milliliters and swish and spit out by oral route every 3 hours
lidocaine 4 % (40 mg/mL) mucosal solution
- Dosage information is not available
lidocaine 2 % mucosal solution
- 15 milliliters and swish and spit out by oral route every 3 hours
lidocaine 4 % (40 mg/mL) mucosal solution
- Dosage information is not available
Administration of local anesthesia
- 15 milliliters and swish and spit out by oral route every 3 hours
- 15 milliliters and swish and swallow by oral route every 3 hours
Mouth irritation
- 15 milliliters and swish and spit out by oral route every 3 hours
- 15 milliliters and swish and swallow by oral route every 3 hours
Suppression of the gag reflex
- 15 milliliters and swish and spit out by oral route every 3 hours
- 15 milliliters and swish and swallow by oral route every 3 hours
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Heart block
- Shock
Severe
Moderate
- None
LIDOCAINE HCL VISCOUS (LIDOCAINE HCL)
- Administration of local anesthesia
- Mouth irritation
- Suppression of the gag reflex
- None
- None
More Frequent
Severe
Less Severe
- Angioedema
- Dermatitis due to topical drug
- Erythema
- Pruritus of skin
- Skin rash
- Stinging of skin
- Urticaria
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute respiratory insufficiency
- Anaphylaxis
- Bradycardia
- Cardiac arrhythmia
- CNS toxicity
- Cyanosis
- Drowsy
- Eyelid edema
- Headache disorder
- Hypotension
- Methemoglobinemia
- Respiratory depression
- Seizure disorder
- Tremor
- Unconsciousness
Less Severe
- Acute confusion
- Apprehension
- Blurred vision
- Dizziness
- Edema
- Euphoria
- Nervousness
- Sensation of cold
- Sensation of warmth
- Tinnitus
- Twitching
- Vomiting
Contraindicated
None
Severe Precaution
Lidocaine (Viscous)
Risk of seizure, cardiopulmonary arrest and death. Not to be used for teething pain. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged or repeated application. Use only when safer alternatives have failed.
Risk of seizure, cardiopulmonary arrest and death. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged or repeated application. Limit use for when safer alternatives have failed.
- 1 Day – 3 Years
- Risk of seizure, cardiopulmonary arrest and death. Not to be used for teething pain. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged or repeated application. Use only when safer alternatives have failed.
- Risk of seizure, cardiopulmonary arrest and death. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged or repeated application. Limit use for when safer alternatives have failed.
- 3 Years – 16 Years
- Risk of seizure, cardiopulmonary arrest and death. Not to be used for teething pain. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged or repeated application. Use only when safer alternatives have failed.
- Risk of seizure, cardiopulmonary arrest and death. Monitor for CNS toxicity (e.g. restlessness, dizziness, drowsiness, blurred vision) with prolonged or repeated application. Limit use for when safer alternatives have failed.
Management or Monitoring Precaution
None
Lidocaine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
Lidocaine
Amount excreted reported to be low with low infant oral bioavailability
General | Excretion Potential | Effect on Infant | Notes |
No known risks; does not adversely affect lactation | Excreted | Not known; no or inclusive data | Amount excreted reported to be low with low infant oral bioavailability |
Contraindicated
None
Precaution Exists
Select Anesthetics
General-May be more sensitive to CNS and cardiac adverse reactions. Consider dose reduction due to reduced clearance in the elderly.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | N | Y | Y | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- Use of this medication by children younger than 3 years has caused serious (sometimes fatal) side effects, including seizure and slowed/stopped heart. If this medication is prescribed for use by a child younger than 3 years, carefully follow the doctor's directions. Do not increase the dose or give this medication more often than directed.<br /><br />Do not use this medication to treat teething pain in infants and young children unless directed by the doctor. Talk with the doctor about other ways to treat teething pain. Keep this product in a safe place away from children.
Mouth irritation | |
K13.79 | Other lesions of oral mucosa |
0-9 | A-Z |
---|---|
K13.79 | Other lesions of oral mucosa |